{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:30:18Z","timestamp":1793896218208,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of the current study is to assess the prevalence of different categories of thyroid dysfunction and their associated risk factors among the modern urban population of Tehran, the capital of Iran.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The present investigation is a sub-study of the HAMRAH study, a population-based prospective study designed to assess the prevalence of traditional cardiovascular risk factors and their changes through a 10-year follow-up. 2228 (61% female) adults aged between 30 and 75 years old and with no overt cardiovascular diseases were selected through a multistage cluster randomized sampling. Blood levels of thyroid-stimulating hormone (TSH), thyroxin (T4), and triiodothyronine (T3) were measured with the aim of assessing the prevalence of abnormal thyroid function status among the modern urban Iranian population, and in order to report the total prevalence of participants with clinical hypo- or hyperthyroidism, the number of individuals taking thyroid-related drugs were added to the ones with overt thyroid dysfunction. A subgroup analysis was also performed to determine the associated risk factors of thyroid dysfunction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of thyroid dysfunction among the total population was 7% (95%CI: 5.9 \u2212\u20098%) and 0.4% (95% CI: 0.1 \u2212\u20090.6%) for subclinical and overt hypothyroidism, and 1.6% (95% CI: 1 \u2212\u20092%) and 0.2% (95% CI: 0 \u2212\u20090.3%) for subclinical and overt hyperthyroidism, respectively. Clinical thyroid dysfunction was detected in 10.3% of the study population (9.4% had clinical hypo- and 0.9% had clinical hyperthyroidism). In the subgroup analysis, thyroid dysfunction was significantly more prevalent among the female participants (<jats:italic>P<\/jats:italic>-value\u2009=\u20090.029).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the current study, the prevalence of different categories of abnormal thyroid status, and also the rate of clinical hypo- and hyperthyroidism was assessed using the data collected from the first phase of the HAMRAH Study. In this study, we detected a higher prevalence of clinical and subclinical hypothyroidism among the Iranian population compared to the previous studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01524-x","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T03:01:56Z","timestamp":1701831716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased prevalence of thyroid dysfunction in Tehran \u2013 HAMRAH study"],"prefix":"10.1186","volume":"23","author":[{"given":"Zahra","family":"Ghaemmaghami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Firoozbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delara","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Khodabandelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Baay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Alemzadeh-Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Boudagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Pouraliakbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeganeh","family":"Pasebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Khalilpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Arabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Bakhshandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"issue":"1","key":"1524_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40001-017-0260-2","volume":"22","author":"A Aminorroaya","year":"2017","unstructured":"Aminorroaya A, Meamar R, Amini M, Feizi A, Tabatabae A, Faghih Imani E. Incidence of thyroid dysfunction in an Iranian adult population: the predictor role of thyroid autoantibodies: results from a prospective population-based cohort study. Eur J Med Res. 2017;22(1):21.","journal-title":"Eur J Med Res"},{"issue":"4","key":"1524_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4103\/ejim.ejim_22_19","volume":"31","author":"NM Rashad","year":"2019","unstructured":"Rashad NM, Samir GM. Prevalence, risks, and comorbidity of thyroid dysfunction: a cross-sectional epidemiological study. Egypt J Intern Med. 2019;31(4):635\u201341.","journal-title":"Egypt J Intern Med"},{"issue":"2","key":"1524_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1524_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"A Garmendia Madariaga","year":"2014","unstructured":"Garmendia Madariaga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Suppl","key":"1524_CR5","first-page":"e84727","volume":"16","author":"A Amouzegar","year":"2018","unstructured":"Amouzegar A, Mehran L, Takyar M, Abdi H, Azizi F. Tehran thyroid study (TTS). Int J Endocrinol Metab. 2018;16(4 Suppl):e84727.","journal-title":"Int J Endocrinol Metab"},{"issue":"7","key":"1524_CR6","first-page":"418","volume":"16","author":"F Azizi","year":"2013","unstructured":"Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y. Natural course of thyroid Disease profile in a population in nutrition transition: Tehran thyroid study. Arch Iran Med. 2013;16(7):418\u201323.","journal-title":"Arch Iran Med"},{"issue":"5","key":"1524_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1210\/er.2003-0033","volume":"26","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26(5):704\u201328.","journal-title":"Endocr Rev"},{"issue":"3","key":"1524_CR8","first-page":"262","volume":"12","author":"A Aminorroaya","year":"2009","unstructured":"Aminorroaya A, Janghorbani M, Amini M, Hovsepian S, Tabatabaei A, Fallah Z. The prevalence of thyroid dysfunction in an iodine-sufficient area in Iran. Arch Iran Med. 2009;12(3):262\u201370.","journal-title":"Arch Iran Med"},{"issue":"2","key":"1524_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40200-018-0367-1","volume":"17","author":"SM Sajjadi-Jazi","year":"2018","unstructured":"Sajjadi-Jazi SM, Sharifi F, Varmaghani M, Meybodi HA, Farzadfar F, Larijani B. Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis. J Diabetes Metab Disord. 2018;17(2):345\u201355.","journal-title":"J Diabetes Metab Disord"},{"issue":"12","key":"1524_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/thy.1998.8.1179","volume":"8","author":"P Lind","year":"1998","unstructured":"Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I. Epidemiology of thyroid Diseases in iodine sufficiency. Thyroid. 1998;8(12):1179\u201383.","journal-title":"Thyroid"},{"issue":"2","key":"1524_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/rcm.rcm_17_20","volume":"9","author":"H Bakhshandeh","year":"2020","unstructured":"Bakhshandeh H, Maleki M, Noohi F, Boudagh S, Khalili Y, Alizadehasl A, et al. Heart Assessment and Monitoring in Rajaie Hospital (HAMRAH): a Population based Cohort Study. Res Cardiovasc Med. 2020;9(2):29\u201334.","journal-title":"Res Cardiovasc Med"},{"issue":"11","key":"1524_CR12","first-page":"950","volume":"36","author":"A Amouzegar","year":"2013","unstructured":"Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F. Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study. J Endocrinol Investig. 2013;36(11):950\u20134.","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"1524_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/thy.2016.0409","volume":"27","author":"A Amouzegar","year":"2017","unstructured":"Amouzegar A, Ghaemmaghami Z, Beigy M, Gharibzadeh S, Mehran L, Tohidi M, et al. Natural course of Euthyroidism and clues for early diagnosis of thyroid dysfunction: Tehran thyroid study. Thyroid. 2017;27(5):616\u201325.","journal-title":"Thyroid"},{"issue":"11","key":"1524_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.34172\/aim.2021.118","volume":"24","author":"S Shahrokh Esfahani","year":"2021","unstructured":"Shahrokh Esfahani S, Tabatabaee A, Aminorroaya A, Amini M, Feizi A, Janghorbani M, et al. Isfahan thyroid cohort study (ITCS). Arch Iran Med. 2021;24(11):788\u201395.","journal-title":"Arch Iran Med"},{"issue":"03","key":"1524_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-0042-117279","volume":"49","author":"L Mehran","year":"2017","unstructured":"Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Thyroid function and metabolic syndrome: a population-based thyroid study. Horm Metab Res. 2017;49(03):192\u2013200.","journal-title":"Horm Metab Res"},{"key":"1524_CR16","doi-asserted-by":"crossref","unstructured":"Amouzegar A, Heidari M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. The association between blood pressure and normal range thyroid function tests in a population based Tehran thyroid study. Horm Metab Res. 2015:151\u20136.","DOI":"10.1055\/s-0035-1564131"},{"issue":"1","key":"1524_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76\u2013131.","journal-title":"Endocr Rev"},{"issue":"10","key":"1524_CR18","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1210\/jc.2003-032061","volume":"89","author":"JJ D\u00edez","year":"2004","unstructured":"D\u00edez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89(10):4890\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1524_CR19","unstructured":"WHO. Cardiovascular Diseases (CVDs) 2021 [updated 11 June 2021]. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"issue":"4","key":"1524_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid Disease prevalence study. Arch Intern Med. 2000;160(4):526\u201334.","journal-title":"Arch Intern Med"},{"key":"1524_CR21","unstructured":"Prevalence and Impact of Thyroid Disease. Available from: https:\/\/www.thyroid.org\/media-main\/press-room\/."},{"issue":"1","key":"1524_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/13696998.2021.1900202","volume":"24","author":"Z Hepp","year":"2021","unstructured":"Hepp Z, Lage MJ, Espaillat R, Gossain VV. The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study. J Med Econ. 2021;24(1):440\u20136.","journal-title":"J Med Econ"},{"key":"1524_CR23","doi-asserted-by":"crossref","unstructured":"Leso V, Vetrani I. The Impact of Thyroid Diseases on the Working Life of Patients: A Systematic Review. 2020;17(12).","DOI":"10.3390\/ijerph17124295"},{"issue":"1","key":"1524_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"13","key":"1524_CR25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/archinte.167.13.1428","volume":"167","author":"BO Asvold","year":"2007","unstructured":"Asvold BO, Bj\u00f8ro T, Nilsen TI, Vatten LJ. Tobacco Smoking and thyroid function: a population-based study. Arch Intern Med. 2007;167(13):1428\u201332.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1524_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49540-z","volume":"9","author":"N Diab","year":"2019","unstructured":"Diab N, Daya NR, Juraschek SP, Martin SS, McEvoy JW, Schulthei\u00df UT, et al. Prevalence and risk factors of thyroid dysfunction in older adults in the community. Sci Rep. 2019;9(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"1","key":"1524_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12902-021-00743-4","volume":"21","author":"M Mahdavi","year":"2021","unstructured":"Mahdavi M, Amouzegar A, Mehran L, Madreseh E, Tohidi M, Azizi F. Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study. BMC Endocr Disorders. 2021;21(1):89.","journal-title":"BMC Endocr Disorders"},{"issue":"6","key":"1524_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-119-6-199309150-00009","volume":"119","author":"SJ Mandel","year":"1993","unstructured":"Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid Disease. Ann Intern Med. 1993;119(6):492\u2013502.","journal-title":"Ann Intern Med"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01524-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T03:04:13Z","timestamp":1701831853000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01524-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01524-x","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"31 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the Rajaie cardiovascular medical and research center (RHC.AC.IR.REC.1396.22). All participants received a detailed explanation about the aims and stages of the HAMRAH study and a fully informed consent was obtained from every single individual for participating in the study and being followed up for 10 years. The study was performed in accordance with Declaration of Helsinki. All data gathered during this study were confidential and participants were free to leave the study at any time desired.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}